Interferon beta-1b biosimilar (PanPharmaceuticals)
干扰素β-1b生物类似药 (PanPharmaceuticals)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameInterferon beta-1b biosimilar (PanPharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesHarvest Moon
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A